Blockbuster Drugs Just Went Generic in 2024 — Here's What That Means for Your Wallet
Every year, a new batch of brand-name drugs loses its patent protection — and every year, millions of Americans get the chance to dramatically cut their medication costs without changing what they're taking. 2024 is shaping up to be a particularly significant year for generic drug launches, with several high-profile, widely-used medications entering the generic market.
If you're currently paying full price (or close to it) for any of the drugs on this list, this article could be worth hundreds of dollars to you. Let's get into it.
Why 2024 Is a Big Year for Generic Launches
The wave of new generics hitting shelves this year is partly the result of a patent cliff that's been building for several years. Many drugs approved in the early 2000s are now reaching the end of their exclusivity windows. Add to that the FDA's continued push to accelerate generic approvals under GDUFA (Generic Drug User Fee Amendments), and 2024 is delivering a meaningful expansion in affordable medication options.
When a drug goes generic, competition among manufacturers typically drives the price down by 80–90% within the first year. For patients paying out of pocket or dealing with high-deductible insurance plans, that's not a small thing. That's the difference between filling a prescription and skipping it.
Newly Generic Medications Worth Knowing About in 2024
1. Eliquis (Apixaban) — Blood Thinner
Brand-name average retail price: $550–$600/month Estimated generic price: $50–$80/month Potential savings: Up to $500/month
This one is huge. Apixaban — sold as Eliquis by Bristol-Myers Squibb and Pfizer — is one of the most prescribed blood thinners in the United States, used by millions of Americans to prevent strokes and blood clots. It has long been one of the most expensive common medications on the market, with many patients relying on manufacturer coupons just to afford it.
Generic apixaban became available in early 2024 following a patent settlement, and the savings are dramatic. If you or someone in your family is on Eliquis, talking to your doctor about switching to generic apixaban should be a priority conversation.
How to switch: Ask your prescribing physician to write a new prescription for generic apixaban (or simply authorize a generic substitution at the pharmacy). Most pharmacies will automatically substitute the generic if your doctor has indicated "dispense as written" is not required.
2. Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) — HIV Treatment
Brand-name average retail price: $3,800–$4,200/month Generic timeline: First generics entering development/approval pipeline in 2024 Expected savings upon availability: 60–80%
Biktarvy is one of the most commonly prescribed antiretroviral regimens for HIV treatment in the U.S. Its price has long been a significant barrier for patients without robust insurance coverage. While full generic availability is still working through the regulatory pipeline in 2024, this year marks the beginning of that process — with meaningful generic competition expected to arrive in the next 1–2 years.
If you're currently on Biktarvy, it's worth monitoring this space closely and discussing options with your HIV specialist, including any available patient assistance programs in the interim.
3. Entresto (Sacubitril/Valsartan) — Heart Failure
Brand-name average retail price: $600–$700/month Generic status: Patent challenges underway; generic entries expected in 2024–2025 Estimated generic price: $80–$120/month
Entresto, used to treat heart failure with reduced ejection fraction, has been a breakthrough medication for cardiac patients — but at a price that's put it out of reach for many. Generic sacubitril/valsartan is working its way through approval processes, with some generic manufacturers having reached patent settlements that allow market entry in 2024.
Given that heart failure is a chronic, lifelong condition for most patients, the long-term savings here are staggering.
4. Ozempic/Wegovy (Semaglutide) — Diabetes & Weight Management
Brand-name price: $900–$1,400/month Generic outlook: Not yet — but compounded versions and biosimilar discussions are active in 2024
Okay, this one needs a nuance flag. Semaglutide — the active ingredient in Ozempic and Wegovy — is not going fully generic in 2024. Novo Nordisk's patents don't expire for several more years. However, 2024 has seen significant regulatory activity around compounded semaglutide (produced by licensed compounding pharmacies during periods of shortage) and early biosimilar development.
This is a rapidly evolving space. If you're currently paying out of pocket for semaglutide, it's worth having an ongoing conversation with your provider about alternatives and monitoring the regulatory landscape closely.
5. Vyvanse (Lisdexamfetamine) — ADHD Treatment
Brand-name average retail price: $350–$400/month Generic price: $60–$90/month Potential savings: Up to $300/month
Generic lisdexamfetamine became available in 2023 and has continued to expand in availability through 2024, with more manufacturers receiving approval and supply stabilizing after early shortages. If you've been holding off on switching because of availability concerns, now is a good time to check again.
This is particularly impactful for families managing ADHD in children or adults who take this medication daily, long-term.
How to Find Out If Your Medication Has Gone Generic
The easiest approach is to ask your pharmacist directly. They have access to real-time formulary and availability information and can tell you on the spot whether a generic exists and what the price difference looks like.
You can also:
- Search the FDA's Approved Drug Products database (the Orange Book) at accessdata.fda.gov
- Check GoodRx or similar platforms and search for both the brand and generic name
- Call GenericMeds Direct — we're happy to help you figure out if a more affordable option exists for your prescription
Tips for Making the Switch Smoothly
Talk to your doctor first. In most cases, switching to a generic is medically straightforward. But for certain medications — like thyroid drugs, some seizure medications, or anticoagulants — your doctor may want to monitor you during the transition. Always loop them in.
Watch for appearance changes. Generic medications often look different from their brand-name counterparts — different shape, different color, sometimes different size. This is completely normal and doesn't indicate a different drug. The active ingredient is the same.
Keep an eye on your response. For most people, the switch is seamless. But if you notice anything unexpected after switching, report it to your doctor and pharmacist. It's rare, but individual responses can vary.
Don't assume your insurance knows best. As we've covered, insurance copays aren't always the cheapest option. Compare your insurance price against cash prices through direct pharmacies before assuming you're getting the best deal.
The Bigger Picture
Every dollar saved on a generic medication is a dollar that stays in your pocket — or goes toward the rest of your healthcare. At GenericMeds Direct, we track new generic approvals closely so you don't have to. Our whole reason for existing is to make sure that when a more affordable option becomes available, you actually know about it and can access it without jumping through hoops.
Big Pharma prices are built on exclusivity. Generics are built on competition. And competition, in this case, is very much your friend.
